Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Aug;12(2):318–323. doi: 10.1128/iai.12.2.318-323.1975

Antigenic heterogeneity among pyocins of Pseudomonas aeruginosa.

J C Allen, P C Kelly
PMCID: PMC415286  PMID: 51006

Abstract

We investigated the effect of FeSO4 on phagocytosis-associated, increased oxidative metabolism via the hexose monophosphate shunt, with special attention to its effect on H2O2 levels. The availability of glutathione peroxidase and glutathione reductase for H2O2 disposal and hexose monophosphate shunt stimulation also are evaluated. The results show an impairment of phagocytosis-associated hexose monophosphate shunt activity together with an increase both of resting and phagocytosing formate oxidation. These apparently paradoxical findings are resolved by demonstrating a direct enhancement of formate oxidation by FeSO4 in a cell-free system. In addition, measurement of H2O2 concentrations via scopoletin fluorescence shows reduction of H2O2 by FeSO4. There is no effect on either glutathione peroxidase or glutathione reductase activities. These data suggest that one mechanism of FeSO4 impairment of microbicidal activity is by its removal of H2O2.

Full text

PDF
318

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AMANO T., GOEBEL W. F., SMIDTH E. M. Colicine K. III. The immunological properties of a substance having colicine K activity. J Exp Med. 1958 Nov 1;108(5):731–752. doi: 10.1084/jem.108.5.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Crowder J. G., Devlin H. B., Fisher M., White A. Heat-stable opsonins in sera of patients with Pseudomonas infections. J Lab Clin Med. 1974 Jun;83(6):853–859. [PubMed] [Google Scholar]
  3. Crowder J. G., White A. A serologic response in human pseudomonas infection. J Lab Clin Med. 1970 Jan;75(1):128–136. [PubMed] [Google Scholar]
  4. Diaz E., Mosovich L. L., Neter E. Serogroups of Pseudomonas aeruginosa and the immune response of patients with cystic fibrosis. J Infect Dis. 1970 Mar;121(3):269–274. doi: 10.1093/infdis/121.3.269. [DOI] [PubMed] [Google Scholar]
  5. Farmer J. J., 3rd, Herman L. G. Epidemiological fingerprinting of Pseudomonas aeruginosa by the production of and sensitivity of pyocin and bacteriophage. Appl Microbiol. 1969 Nov;18(5):760–765. doi: 10.1128/am.18.5.760-765.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Govan J. R., Gillies R. R. Further studies in the pyocine typing of Pseudomonas pyocyanea. J Med Microbiol. 1969 Feb;2(1):17–25. doi: 10.1099/00222615-2-1-17. [DOI] [PubMed] [Google Scholar]
  7. HUTTON J. J., GOEBEL W. F. The isolation of colicine V and a study of its immunological properties. J Gen Physiol. 1962 Mar;45(4):125–141. doi: 10.1085/jgp.45.4.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Maeda A., Nomura M. Interaction of colicins with bacterial cells. I. Studies with radioactive colicins. J Bacteriol. 1966 Feb;91(2):685–694. doi: 10.1128/jb.91.2.685-694.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nomura M. Colicins and related bacteriocins. Annu Rev Microbiol. 1967;21:257–284. doi: 10.1146/annurev.mi.21.100167.001353. [DOI] [PubMed] [Google Scholar]
  10. REEVES P. THE BACTERIOCINS. Bacteriol Rev. 1965 Mar;29:24–45. doi: 10.1128/br.29.1.24-45.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Zabransky R. J., Day F. E. Pyocine typing of clinical strains of Pseudomonas aeruginosa. Appl Microbiol. 1969 Feb;17(2):293–296. doi: 10.1128/am.17.2.293-296.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES